IPP Bureau
BioFluidica to introduce next-generation biomarker isolation platform
By IPP Bureau - April 06, 2022
BioFluidica LiquidScan harnesses the power of microfluidics
Singlera Genomics announces research collaboration with Astellas Pharma
By IPP Bureau - April 06, 2022
The aim is to pursue methylation-based tools to better understand biological reactions to pharmaceuticals
GE Healthcare and Elekta sign global collaboration agreement
By IPP Bureau - April 06, 2022
GE Healthcare and Elekta aim to meet the major need for radiotherapy solutions across both developed and developing markets
Iktos and Teijin Pharma to co-develop technology for small molecule drug discovery
By IPP Bureau - April 06, 2022
Iktos and Teijin Pharma will collaborate in developing new AI technology aiming to bring further improvement and speed to the drug design process
ENTOD Pharma bullish on Macushield sales
By IPP Bureau - April 06, 2022
Macushield tablets assist with age-related macular degeneration, diabetic retinopathy and improves overall vision
Revenue growth to moderate, non-Covid-19 revenue to drive profitability
By IPP Bureau - April 06, 2022
Ind-Ra maintains a neutral outlook for healthcare in FY23
Aster MIMS Hospital completes 50 kidney swap transplants
By IPP Bureau - April 06, 2022
The kidney swap transplant procedure provides a solution to a critical shortage of compatible kidneys for patients suffering from kidney failures in India
Alvotech and STADA pave way to launching Hukyndra
By IPP Bureau - April 06, 2022
All intellectual-property disputes related to the market entry of Alvotech’s AVT02 (adalimumab) in the U.S. and Europe are now resolved
Aizon partners with TetraScience to help pharma companies speed up drug manufacturing efficiently
By IPP Bureau - April 06, 2022
The partnership demonstrates increasing adoption of tetra data to create unrestricted innovation
AGC to invest $100 million for expanding synthetic pharmaceutical production in Spain
By IPP Bureau - April 06, 2022
The new facility is scheduled to start operation in the first half of 2024
Agilent joins AMBIC to advance biomanufacturing
By IPP Bureau - April 05, 2022
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
Feedback Medical brings Bleepa to India
By IPP Bureau - April 05, 2022
Announces pilot project for rapid, remote diagnosis of tuberculosis
Enteris BioPharma gets featured on its oral drug delivery technology
By IPP Bureau - April 05, 2022
Highlighted as game changer in drug development & delivery special feature on innovative technologies for improving drug solubility and bioavailability
Vipergen’s DNA based drug discovery partnership with Theseus Pharma
By IPP Bureau - April 05, 2022
Under the terms of the agreement, Vipergen will apply its in-living-cell DNA-encoded library (DEL) screening platform to discover novel small-molecule compounds that bind to a selected Theseus kinase target
Abott gets USFDA approval for leadless pacemaker
By IPP Bureau - April 05, 2022
Aveir VR is specifically designed to be retrieved when therapy needs to evolve or the device needs to be replaced
